Also trades as: 6869.T (JPX) · $vol 46M · SSMXY (OTC) · $vol 1M

$12.04

+0.00 (+0.00%)

OTC · Healthcare · Medical - Specialties · Tech Score Neutral · Power 62 · $7.5B mcap · 425M float · 0.0000% daily turnover · Short 99% of daily vol

Revenue

$503.2B -1.1% ▼

5Y CAGR: +10.5%

Gross Profit

$257.3B -5.4% ▼

5Y CAGR: +10.8%

Operating Income

$62.6B -28.6% ▼

5Y CAGR: +4.2%

Net Income

$35.7B -33.5% ▼

5Y CAGR: +2.3%

EPS (Diluted)

$57.52 -33.2% ▼

5Y CAGR: -17.7%

EBITDA

$109.3B -10.3% ▼

5Y CAGR: +7.2%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$363.8B	$410.5B	$461.5B	$508.6B	$503.2B
YoY Growth	+19.2%	+12.8%	+12.4%	+10.2%	-1.1%
Cost of Revenue	$173.2B	$194.4B	$219.0B	$236.7B	$245.9B
Gross Profit	$190.6B	$216.1B	$242.5B	$272.0B	$257.3B
Gross Margin	52.4%	52.6%	52.5%	53.5%	51.1%
R&D Expenses	$26.8B	$31.1B	$31.4B	$31.5B	$29.3B
SG&A Expenses	$94.2B	$112.4B	$133.8B	$150.8B	$165.4B
Operating Expenses	$123.2B	$142.4B	$164.1B	$184.4B	$194.7B
Operating Income	$67.4B	$72.7B	$77.3B	$87.6B	$62.6B
Operating Margin	18.5%	17.7%	16.7%	17.2%	12.4%
Interest Expense	$909M	$1.6B	$2.4B	$3.5B	$4.4B
Income Before Tax	$64.3B	$68.7B	$74.6B	$79.2B	$49.4B
Tax Expense	$20.3B	$23.0B	$24.8B	$25.6B	$13.8B
Net Income	$44.1B	$45.8B	$49.6B	$53.7B	$35.7B
Net Margin	12.1%	11.2%	10.8%	10.6%	7.1%
EPS (Diluted)	$70.16	$72.91	$79.24	$86.05	$57.52
EBITDA	$92.7B	$107.2B	$116.0B	$121.8B	$109.3B
Shares Outstanding	209M	628M	626M	624M	623M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$111.9B	$130.5B	$124.4B	$141.8B	$105.7B	$128.6B	$128.8B	$139.7B
Cost of Revenue	$51.9B	$59.3B	$56.9B	$68.6B	$51.3B	$59.5B	$63.6B	$71.2B
Gross Profit	$60.0B	$71.3B	$67.5B	$73.2B	$54.5B	$69.1B	$65.1B	$68.5B
Gross Margin	53.6%	54.6%	54.3%	51.6%	51.5%	53.7%	50.6%	49.0%
R&D Expenses	$7.4B	$7.9B	$7.3B	$8.9B	$6.4B	$6.9B	$7.2B	$8.8B
SG&A Expenses	$36.0B	$36.4B	$37.6B	$40.9B	$38.3B	$40.1B	$42.4B	$44.4B
Operating Expenses	$43.4B	$44.2B	$44.9B	$51.9B	$43.8B	$47.0B	$49.6B	$53.2B
Operating Income	$16.7B	$27.0B	$22.6B	$21.3B	$10.6B	$22.0B	$15.5B	$15.3B
Operating Margin	14.9%	20.7%	18.2%	15.0%	10.1%	17.1%	12.0%	10.9%
Interest Expense	$590M	$524M	$520M	$1.0B	$711M	$918M	$848M	$1.7B
Income Before Tax	$17.0B	$21.3B	$23.5B	$17.4B	$7.9B	$22.4B	$17.5B	$1.6B
Tax Expense	$6.0B	$6.4B	$6.9B	$6.3B	$3.4B	$7.8B	$2.9B	-$274M
Net Income	$11.0B	$15.0B	$16.6B	$11.1B	$4.6B	$14.7B	$14.7B	$1.8B
Net Margin	9.9%	11.5%	13.4%	7.8%	4.3%	11.4%	11.4%	1.3%
EPS (Diluted)	$17.69	$24.01	$26.63	$17.72	$7.30	$24.00	$23.53	$2.86
EBITDA	$26.5B	$37.2B	$32.4B	$33.8B	$21.4B	$36.0B	$27.5B	$27.0B
Shares Outstanding	624M	624M	624M	624M	624M	623M	623M	620M

SSMXF OTC